Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cardiff Oncology (CRDF) Shares Issued (2016 - 2025)

Historic Shares Issued for Cardiff Oncology (CRDF) over the last 14 years, with Q3 2025 value amounting to $25000.0.

  • Cardiff Oncology's Shares Issued fell 9966.22% to $25000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $44.2 million, marking a year-over-year increase of 38020.64%. This contributed to the annual value of $53.4 million for FY2024, which is N/A changed from last year.
  • According to the latest figures from Q3 2025, Cardiff Oncology's Shares Issued is $25000.0, which was down 9966.22% from $3000.0 recorded in Q1 2025.
  • In the past 5 years, Cardiff Oncology's Shares Issued registered a high of $44.2 million during Q4 2024, and its lowest value of $3000.0 during Q1 2025.
  • Its 4-year average for Shares Issued is $8.8 million, with a median of $1.5 million in 2021.
  • Per our database at Business Quant, Cardiff Oncology's Shares Issued surged by 355.13% in 2021 and then tumbled by 9966.22% in 2025.
  • Quarter analysis of 4 years shows Cardiff Oncology's Shares Issued stood at $15.0 million in 2021, then tumbled by 99.5% to $75000.0 in 2022, then soared by 58800.0% to $44.2 million in 2024, then plummeted by 99.94% to $25000.0 in 2025.
  • Its Shares Issued stands at $25000.0 for Q3 2025, versus $3000.0 for Q1 2025 and $44.2 million for Q4 2024.